---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-061028"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2024-07-12T23:59:59+00:00"
generated_at: "2026-05-31T20:57:13.314146+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received Nasdaq notice on July 10, 2024 for non-compliance with minimum $1.00 bid price rule over 30 consecutive days.
- Compliance deadline is January 6, 2025; can regain if bid price closes at $1.00+ for 10 business days.
- If not cured, may qualify for additional 180-day period if other initial listing standards are met.
- Company may consider a reverse stock split to cure the deficiency.

## SEC filing metadata
- accession: 0001213900-24-061028
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2024-07-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390024061028/0001213900-24-061028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390024061028/ea0209346-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-061028
- JSON: https://secwatch.observer/filing/0001213900-24-061028.json
- Plain text: https://secwatch.observer/filing/0001213900-24-061028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.